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SCIENTIFIC REPORT
Results of high-density silicone oil as a tamponade agent in
macular hole retinal detachment in patients with high myopia
Benson T O Cheung, Timothy Y Y Lai, Can Y F Yuen, Wico W K Lai, Chi-Wai Tsang, Dennis S C Lam
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Background: To evaluate the use of high-density silicone oil
(HDSO) as a tamponade agent for retinal detachment
secondary to myopic macular hole.
Methods: 12 eyes of 12 patients with macular hole retinal
detachment underwent pars plana vitrectomy, internal limiting
membrane peeling and HDSO tamponade. No posturing was
required postoperatively and HDSO was removed 3–4 months
later. Outcome measures included macular hole closure and
retinal attachment rates, best-corrected visual acuity (BCVA),
and intraoperative and postoperative complications.
Results: The mean age of the patients was 67.8 years and the
mean spherical equivalent refractive error was 213.4 diopters.
After the removal of HDSO, 10 (83%) eyes had macular hole
closure with retinal reattachment without any tamponade. One
eye had retinal reattachment after re-operation and the other
refused further surgery. At the last follow-up, the median BCVA
improved from 20/800 to 20/600 (p = 0.046). A transient
increase in intraocular pressure was observed in 5 (42%) eyes
and one eye each developed mild oil emulsification and
transient peripheral choroidal detachment. None of the eyes
was found to have severe intraocular inflammation post-
operatively.
Conclusions: HDSO seemed to be an effective tamponade
agent for myopic macular hole retinal detachment. Further
prospective controlled studies seem warranted.
R
etinal detachment with a macular hole occurs most
commonly in highly myopic eyes, particularly in associa-
tion with posterior staphyloma.1–3 The exact pathogenesis
is uncertain but is thought to be due to tangential traction,
posterior staphyloma and retinal pigment epithelium atro-
phy.2 4–6 Various procedures have been performed for macular
hole retinal detachment and include pars plana vitrectomy with
gas or silicone oil tamponade, macular buckling and scleral
shortening.7–13 Removal of epiretinal membrane and internal
limiting membrane (ILM) has also been performed to improve
the success rate.4–6 14–16 However, despite these procedures, re-
detachment may still develop and some eyes will require
multiple surgeries to achieve reattachment.1–3 7 8 Loss of
chorioretinal tissue and retinal pigment epithelium atrophy
are some factors for the low reattachment rate. Poor compliance
to face-down positioning after gas tamponade postoperatively
may also potentially reduce the anatomical success rate.
Recently, high-density silicone oil (HDSO; Oxane HD, Bausch
& Lomb, Rochester, New York, USA) was developed as a
vitreous substitute for endotamponade in complicated retinal
detachment, especially in cases with inferior proliferative
vitreoretinopathy. HDSO is a mixture of silicone oil and partially
fluorinated alkanes, and has a relative density of 1.03 g/cm3
and viscosity of 3800 cSt. Previous studies have demonstrated
that HDSO resulted in high attachment rates in complicated
retinal detachment and in persistent macular hole.17–19 The
heavier-than-water property of HDSO enabled it to tamponade
the inferior and posterior retina effectively. Another advantage of
HDSO is that patients can adopt a supine posture postopera-
tively.20 In view of these beneficial properties, we performed a
pilot study to evaluate HDSO as a tamponade agent in macular
hole retinal detachment in patients with high myopia.
PATIENTS AND METHODS
This was a prospective pilot study in which patients with retinal
detachment secondary to myopic macular hole and high
myopia >26.0 D were recruited. Exclusion criteria included
peripheral breaks connected to the macular hole retinal
detachment, maculopathy secondary to age-related macular
degeneration, a history of uveitis and allergy to silicone
material. All surgeries were performed at Hong Kong Eye
Hospital, Hong Kong, between December 2004 and January
2006. Informed consent was obtained from all patients and the
protocol was approved by the ethics committee of the Kowloon
Central Cluster of the Hospital Authority.
Preoperative investigations include best-corrected Snellen
visual acuity (BCVA) testing, intraocular pressure measure-
ment, axial length measurements, slit-lamp examination and
indirect ophthalmoscopy. All surgeries were performed by two
surgeons (BTOC, CYFY). Phacoemulsification with intraocular
lens implantation was also performed in cases with visually
significant cataract. All patients underwent standard three-port
pars plana vitrectomy, followed by the removal of the posterior
hyaloid. ILM peeling was then performed with either 0.15%
trypan blue staining or triamcinolone acetonide, and specimens
were sent for microscopic examination. Fluid/air exchange was
performed, followed by air/HDSO exchange. Postoperatively, all
patients adopted supine posture and were treated with a
tapering course of 1% prednisolone acetate (Pred Forte, Alcon,
Fort Worth, Texas, USA) and 0.5% levofloxacin (Cravit, Santen
Osaka, Japan) eyes drops.
Patients were assessed on day 1, week 1, and months 1, 2 and
3 postoperatively. HDSO was removed 3–4 months postopera-
tively as recommended by the manufacturer, or earlier if
complications arose. Surgical techniques of HDSO removal
included pars plana sclerotomies with placement of infusion
and active aspiration of HDSO using a soft 18 G cannula under
endoillumination and microscopic visualisation. The globe was
then re-filled with balanced salt solution or gas. Patients were
followed on day 1, week 1, and months 1, 2 and 3, and then
every 3 months after HDSO removal. Macular hole status was
evaluated by slit-lamp biomicroscopy and in cases in which the
hole status was doubtful, optical coherence tomography was
performed for confirmation.
The main outcome measures include macular hole closure
and retinal reattachment rates after HDSO removal and
changes in BCVA. Other outcome measures included safety
Abbreviations: BCVA, best-corrected visual acuity; HDSO, high-density
silicone oil; ILM, internal limiting membrane
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parameters such as intraoperative or postoperative complica-
tions. Data were entered into a statistical software (SPSS
V.11.5) for analysis.
RESULTS
A total of 12 eyes of 12 patients were recruited (table 1). The
mean (SD) age was 67.8 (11.1) years (range 49–81 years). The
mean (SD) spherical equivalent refractive error was 213.4
(5.3) D (range 26.0 to 221.0 D) and the mean (SD) axial
length was 28.7 (1.7) mm (range 26.0–30.9 mm). The median
preoperative BCVA was 20/800 (range 20/600 to finger
counting).
Combined pars plana vitrectomy with phacoemulsification
was performed in 7 of 10 phakic patients. ILM was successfully
removed in all 12 eyes, in which 9 had trypan blue staining and
3 had triamcinolone-assisted ILM peeling. Histological exam-
ination confirmed the presence of ILM in all cases (fig 1). One
eye developed a peripheral retinal break intraoperatively and
was treated with endolaser photocoagulation.
Patients were followed for a mean of 12.1 months post-
operatively (range 9–15 months). During the period of HDSO
tamponade, all eyes had complete attachment of the retina and
macular hole closure. In all, 5 (42%) eyes developed a transient
increase in intraocular pressure (range 22–44 mm Hg) and all
were controlled with topical drugs for glaucoma. Other
complications included mild oil emulsification (one eye) and
peripheral choroidal detachment, which resolved sponta-
neously (one eye). Severe intraocular inflammation including
anterior chamber cells >2 or keratic precipitates were not
observed in any eye. After tamponade of 3–4 months, HDSO
was completely removed in all eyes. A total of 10 (83%) eyes
had macular hole closure and complete retinal attachment after
HDSO removal. One eye had reopening of macular hole and
retinal re-detachment 2 weeks after HDSO removal, and re-
operation with perfluorocarbon gas tamponade was performed,
which resulted in macular hole closure and retinal reattach-
ment. Another eye had reopening of macular hole with retinal
and choroidal detachment 3 months after HDSO removal, but
the patient declined further surgery. At the last follow-up, the
median BCVA improved to 20/600 (range 20/200 to hand
movements; Wilcoxon signed rank test, p = 0.046). In all, 11
(92%) eyes had macular hole closure and retinal reattachment
without tamponade at the last follow-up, and all but one eye
had stable or improved vision after surgery.
DISCUSSION
Our pilot study demonstrated that HDSO seemed to be an
effective tamponade agent for myopic macular hole with retinal
detachment. After a mean follow-up of 12 months, 10 (83%) eyes
had macular hole closure with retinal reattachment after one
operation. There was also statistically significant improvement in
the median BCVA. The results compared favourably with other
surgical techniques for myopic macular hole retinal detachment.
Ripandelli et al11 reported that the retinal reattachment rates of
following vitrectomy with gas tamponade and macular buckle
were 73% and 93%, respectively. In another study by Chen et al,13
the primary retinal reattachment rate was only around 50–60%
after vitrectomy and gas tamponade. The anatomical success rate
in our study using HDSO therefore seemed to be comparable with
previous studies and might be higher than gas tamponade. The
heavier-than-water property of HDSO might enable more
efficient tamponade on the retina. Moreover, with HDSO,
patients can adopt a supine posture postoperatively and non-
compliance to face-down positioning as in gas tamponade will
not be an issue.20 Another reason for the relatively high success
rate in our study might be associated with ILM peeling.
Kadonosono et al15 have shown that pars plana vitrectomy with
ILM peeling, followed by gas tamponade for macular hole retinal
detachment had a success rate of around 90%.
One of the concerns in using HDSO is the association with
intraocular inflammation. In a case series reported by Theelen
et al,18 in which 19 eyes underwent vitrectomy and HDSO
tamponade for complicated retinal detachment, granulomatous
Table 1 Preoperative and postoperative details of the 12 patients recruited in the study
Patient
number
Sex/age
(years)/eye
Follow-up
(months)
Refractive
error (D)
Axial
length
(mm)
Symptom
duration
(months)
Preop
lens
status
Combined
phaco + IOL
Preop
visual
acuity
Final
visual
acuity
Final
macular
hole status
Final retina
status
1 F/49/R 15 216.0 27.9 0.5 Phakic No 20/800 20/600 Closed Attached
2 F/73/R 10 212.0 30.5 0.5 PCIOL NA 20/800 20/600 Closed Attached
3 F/80/R 15 215.0 26.8 2 Phakic Yes 20/800 20/600 Closed Attached
4 M/61/L 12 218.0 29.3 3 PCIOL NA 20/600 20/600 Closed Attached
5 F/62/L 15 221.0 30.5 0.25 Phakic Yes 20/800 20/800 Closed Attached
6 M/74/R 12 218.0 30.9 6 Phakic Yes FC FC Open Detached
7 F/81/R 9 27.0 26.0 4 Phakic Yes 20/600 HM Closed Attached
8 F/55/R 12 220.0 30.9 0.25 Phakic No 20/800 20/600 Closed Attached
9 L/70/L 12 26.0 26.8 1 Phakic Yes 20/600 20/200 Closed Attached
10 M/55/R 12 29.0 28.0 1 Phakic No 20/800 20/200 Closed Attached
11 M/72/L 12 211.5 29.0 6 Phakic Yes 20/800 20/600 Closed Attached
12 M/81/L 9 27.0 28.0 6 Phakic Yes 20/600 20/200 Closed Attached
F, female; FC, finger counting; HM, hand movements; IOL, intraocular lens; L, left; M, male; NA, not applicable; PCIOL, posterior chamber IOL; Preop, preoperative;
phaco, phacoemulsification; R, right.
Figure 1 Light microscopy of the surgically removed specimen
demonstrating the acellular internal limiting membrane (periodic acid Schiff
stain, magnification6400).
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inflammation that did not respond to topical steroids was
observed in 7 (37%) eyes. The inflammatory response com-
pletely resolved after HDSO removal. In our series, none of the
patients were found to have such intraocular inflammation
postoperatively. This might be owing to the exchange of
perfluorocarbon liquids directly with HDSO in the study by
Theelen et al18 and dispersion of the two substances might lead
to additional adverse reactions. Our results are consistent with
studies by Wolf et al17 and Rizzo et al,19 in which HDSO was
found to be safe without adverse events including intraocular
inflammation after tamponade of up to 3 months.
The main limitations of our study were the small number of
cases and that combined cataract surgeries were not uniformly
performed in all patients. Another limitation was the lack of
optical coherence tomography evaluation in all patients to
confirm the postoperative macular hole status. Also, despite the
relatively high anatomical success rate, two eyes developed
macular hole reopening with retinal detachment after HDSO
removal. This might be related to insufficient tamponade
duration as myopic macular hole might take longer to close.
Therefore, further studies might consider prolonging the
duration of HDSO tamponade in these cases.
In conclusion, our pilot study showed that HDSO seemed to
be a promising vitreous substitute in retinal detachment
secondary to myopic macular hole. The main advantage is the
relatively high anatomical success rate with the lack of
requirement for prone positioning postoperatively. The
encouraging results suggest that a randomised controlled trial
is warranted to compare its efficacy with other tamponade
agents for macular hole retinal detachment.
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